Abstract
Among patients diagnosed with bipolar disorder (BPD), major depressive disorder (MDD) and schizophrenia (SCZ), poor adherence to psychopharmacologic therapy is common and results in increased health care utilization and costs. Emergence of digital tools that track medication adherence along with general health is useful, but evidence on caregiver valuations of such tools is limited. This study assessed caregivers’ preferences and willingness to pay (WTP) for digital (ingestible sensor pill, medication containers with electronic monitoring, mobile apps, smart pill dispensers) and non-digital (medication dairy, simple pill organizer) tools for caring BPD, MDD and SCZ patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
